109 related articles for article (PubMed ID: 11950909)
21. Endometrial serous carcinoma: its molecular characteristics and histology-specific treatment strategies.
Nakayama K; Nakayama N; Ishikawa M; Miyazaki K
Cancers (Basel); 2012 Aug; 4(3):799-807. PubMed ID: 24213467
[TBL] [Abstract][Full Text] [Related]
22. Histopathological patterns of endometrial carcinoma in a tertiary hospital in North-West Nigeria.
Olatunde OA; Samaila MO; Imam MI; Uchime KE; Dauda SE
Ecancermedicalscience; 2024; 18():1651. PubMed ID: 38425759
[TBL] [Abstract][Full Text] [Related]
23. Endometrial Cancer in a Family With RAD51D Gene Mutation.
Gilmore B; Logan L; McKinnon W; Everett E; Bryant BH
Int J Gynecol Pathol; 2024 Mar; ():. PubMed ID: 38661557
[TBL] [Abstract][Full Text] [Related]
24. Histological Grade of Endometrioid Endometrial Cancer and Relapse Risk Can Be Predicted with Machine Learning from Gene Expression Data.
Gargya P; Bálint BL
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503158
[TBL] [Abstract][Full Text] [Related]
25. Mitotic activity: A systematic literature review of the assessment methodology and prognostic value in feline tumors.
Bertram CA; Donovan TA; Bartel A
Vet Pathol; 2024 Mar; ():3009858241239566. PubMed ID: 38533803
[TBL] [Abstract][Full Text] [Related]
26. Mixed neuroendocrine and endometrioid carcinoma of the endometrium: a rare aggressive malignancy.
Bakshi N; Modi RD; Srivastava M; Badwal S
Int J Gynecol Cancer; 2024 Jan; ():. PubMed ID: 38182264
[No Abstract] [Full Text] [Related]
27. Expanding the spectrum of paratesticular mullerian-origin tumors: Adenocarcinoma with mixed serous and endometrioid features and clear cell carcinoma.
Gupta S; Schoolmeester JK; Cheville JC
Hum Pathol; 2024 Apr; ():. PubMed ID: 38679206
[No Abstract] [Full Text] [Related]
28. Acquisition of APOBEC Mutagenesis and Microsatellite Instability Signatures in the Development of Brain Metastases in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.
Dessources K; Da Cruz Paula A; Pareja F; Stylianou A; Cybulska P; Farmanbar A; Chandarlapaty S; Abu-Rustum NR; Reis-Filho JS; Weigelt B; Mueller JJ
JCO Precis Oncol; 2020; 4():. PubMed ID: 33163849
[No Abstract] [Full Text] [Related]
29. Considering the role of epigenetic mitotic indices in oral cancer screening and risk stratification.
Nwanaji-Enwerem JC
Oral Dis; 2024 Mar; ():. PubMed ID: 38525676
[No Abstract] [Full Text] [Related]
30. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
[TBL] [Abstract][Full Text] [Related]
31. Does human endometrial LGR5 gene expression suggest the existence of another hormonally regulated epithelial stem cell niche?
Tempest N; Baker AM; Wright NA; Hapangama DK
Hum Reprod; 2018 Jun; 33(6):1052-1062. PubMed ID: 29648645
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical Study of ER, PR, Ki67 and p53 in Endometrial Hyperplasias and Endometrial Carcinomas.
Masjeed NMA; Khandeparkar SGS; Joshi AR; Kulkarni MM; Pandya N
J Clin Diagn Res; 2017 Aug; 11(8):EC31-EC34. PubMed ID: 28969139
[TBL] [Abstract][Full Text] [Related]
33. Prognostic importance of DNA ploidy in non-endometrioid, high-risk endometrial carcinomas.
Sorbe B
Oncol Lett; 2016 Mar; 11(3):2283-2289. PubMed ID: 26998163
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival.
Kamal AM; Bulmer JN; DeCruze SB; Stringfellow HF; Martin-Hirsch P; Hapangama DK
Br J Cancer; 2016 Mar; 114(6):688-96. PubMed ID: 26930451
[TBL] [Abstract][Full Text] [Related]
35. An immunohistochemical study on the expression of sex steroid receptors, Ki-67 and cytokeratins 7 and 20 in feline endometrial adenocarcinomas.
Saraiva AL; Payan-Carreira R; Gärtner F; Fortuna da Cunha MR; Rêma A; Faria F; Lourenço LM; Pires Mdos A
BMC Vet Res; 2015 Aug; 11():204. PubMed ID: 26268561
[TBL] [Abstract][Full Text] [Related]
36. DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium.
Pradhan M; Davidson B; Abeler VM; Danielsen HE; Tropé CG; Kristensen GB; Risberg BÅ
Virchows Arch; 2012 Sep; 461(3):291-8. PubMed ID: 22824999
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers in endometrial cancer: Possible clinical applications (Review).
Banno K; Kisu I; Yanokura M; Tsuji K; Masuda K; Ueki A; Kobayashi Y; Yamagami W; Nomura H; Tominaga E; Susumu N; Aoki D
Oncol Lett; 2012 Jun; 3(6):1175-1180. PubMed ID: 22783413
[TBL] [Abstract][Full Text] [Related]
38. Significantly decreased P27 expression in endometrial carcinoma compared to complex hyperplasia with atypia (correlation with p53 expression).
Ozkara SK; Corakci A
Pathol Oncol Res; 2004; 10(2):89-97. PubMed ID: 15188025
[TBL] [Abstract][Full Text] [Related]
39. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
